Estrella Immunopharma Statistics Share Statistics Estrella Immunopharma has n/a
shares outstanding. The number of shares has increased by 2.45%
in one year.
Shares Outstanding n/a Shares Change (YoY) 2.45% Shares Change (QoQ) 2.49% Owned by Institutions (%) n/a Shares Floating 10.99M Failed to Deliver (FTD) Shares 320 FTD / Avg. Volume 0.75%
Short Selling Information The latest short interest is 36.68K, so 0.1% of the outstanding
shares have been sold short.
Short Interest 36.68K Short % of Shares Out 0.1% Short % of Float 0.33% Short Ratio (days to cover) 1.15
Valuation Ratios The PE ratio is -4.98 and the forward
PE ratio is null.
Estrella Immunopharma's PEG ratio is
-0.26.
PE Ratio -4.98 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 306.25 P/FCF Ratio -5.76 PEG Ratio -0.26
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Estrella Immunopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.55,
with a Debt / Equity ratio of 0.
Current Ratio 0.55 Quick Ratio 0.55 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.69K Effective Tax Rate -0.02%
Stock Price Statistics The stock price has increased by 13.91% in the
last 52 weeks. The beta is 0.39, so Estrella Immunopharma's
price volatility has been higher than the market average.
Beta 0.39 52-Week Price Change 13.91% 50-Day Moving Average 1.01 200-Day Moving Average 1.02 Relative Strength Index (RSI) 68.44 Average Volume (20 Days) 42,671
Income Statement
Revenue n/a Gross Profit n/a Operating Income -8.85M Net Income -8.85M EBITDA -8.85M EBIT -8.85M Earnings Per Share (EPS) -0.25
Full Income Statement Balance Sheet The company has 916.92K in cash and 0 in
debt, giving a net cash position of 916.92K.
Cash & Cash Equivalents 916.92K Total Debt n/a Net Cash n/a Retained Earnings -23.93M Total Assets 2.98M Working Capital -7.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.64M
and capital expenditures -1, giving a free cash flow of -7.64M.
Operating Cash Flow -7.64M Capital Expenditures -1 Free Cash Flow -7.64M FCF Per Share -0.21
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
